Eli Lilly's stock is undervalued; defensive healthcare stocks shine amid uncertainty, and Eli Lilly drives growth. Click here ...

In its fourth quarter 2024 investor letter, Parnassus Core Equity Fund emphasized stocks such as Eli Lilly and Company (NYSE:LLY). Eli Lilly and Company (NYSE:LLY) is a pharmaceutical company ...

Parnassus Investments, an investment management company, released the “Parnassus Core Equity Fund” fourth quarter 2024 ...

Eli Lilly (LLY) believes its experimental weight-loss pill could make GLP-1 treatments more accessible worldwide. “We feel that a product like an oral, orforglipron, could serve a significant ...

In its fourth quarter 2024 investor letter, Parnassus Core Equity Fund emphasized stocks such as Eli Lilly and Company (NYSE:LLY). Eli Lilly and Company (NYSE:LLY) is a pharmaceutical company, ...

Eli Lilly (NYSE: LLY) stock has had plenty of good trading sessions over the past year or so, but Monday's sure wasn't among them. The storied pharmaceutical company's shares lost nearly 5% of ...

Late-breaking results from Eli Lilly and Company (LLY ... Findings from the Phase 3 BRAVE-AA-PEDS study were presented in a late-breaker presentation at the American Academy of Dermatology ...

Like many pharma stocks, Eli Lilly (NYSE ... t mean they will disturb today's leaders. Lilly expects data readouts this year from a phase 3 trial of retatrutide, a weight loss candidate it's ...

Eli Lilly (LLY) announced Wednesday that it is ramping up US manufacturing, adding four new sites to help increase the production of key drug ingredients. Three of the four sites will produce ...

In its fourth quarter 2024 investor letter, Parnassus Core Equity Fund emphasized stocks such as Eli Lilly and Company (NYSE ... over the next 12 months. 3. Sit back, relax, and know that you ...

26 (UPI) --Eli Lilly announced plans for four new pharmaceutical ... study linking sexual activity to an infection that 1 in 3 U.S. women contract has provided a new tool to prevent recurrences ...